Tony Turski, a 56-year-old masters athlete from Southern California who finished second in the Masters Men 55-59 Division in 2017, tested positive for Anastrozole.
Anastrozole is used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause (change of life; end of monthly menstrual periods). This medication is also used in women, who have experienced menopause, as a first treatment of breast cancer that has spread within the breast or to other areas of the body.
Anastrozole combats and limits the amount of estrogen secretions in the body, which in turn, maximizes the effects testosterone has on the body.
LIGANDROL – LGD4033
Carlos Castillo from the Latin America Regional tested positive for this and has also received a 4-year sanction.
LGD-4033 is an investigational selective androgen receptor (SARM) modulator for treatment of conditions such as muscle wasting and osteoporosis. Ligandrol works in the same way as other SARM’s: by selectively activating androgen receptors to promote anabolic activity exclusively in muscle and bone.
- CrossFit Promotes Drug Exams in Athletes: Unsplash